Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Fresnillo PLC AGM Information 2022

May 17, 2022

6186_dva_2022-05-17_b12b52ce-67ce-445a-a9ce-ed7bcfe0f0bd.pdf

AGM Information

Open in viewer

Opens in your device viewer

Fresnillo Plc 21 Upper Brook Street London W1K 7PY United Kingdom www.fresnilloplc.com

17 May 2022

Company Number: 06344120

THE COMPANIES ACT 2006

COMPANY LIMITED BY SHARES

RESOLUTIONS OF FRESNILLO PLC (the COMPANY) (passed on 17 May 2022)

At the Annual General Meeting of the members of the Company convened and held on 17 May 2022, the following resolutions were duly passed:

As an Ordinary Resolution:

Resolution 19: Directors' authority to allot

THAT the Directors of the Company be and are hereby generally and unconditionally authorised pursuant to Section 551 of the Companies Act 2006 (or the "Act") to exercise all the powers of the Company to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of US\$122, 815,598, such authority to apply in substitution for all previous authorities pursuant to Section 551 of the Act and provided that this authority shall expire at the end of the next annual general meeting of the Company or on at 6.00 pm on 17 August 2023, whichever is the earlier (unless previously renewed, varied or revoked by the Company at a general meeting) save that the Company may before such expiry make offers and enter into agreements which would, or might, require shares to be allotted or rights to subscribe for or to convert any security into shares to be granted after the authority given by this resolution has expired.

As a Special Resolution:

Resolution 20: Disapplication of pre-emption rights

THAT, subject to the passing of Resolution 19 above, the Board be authorised pursuant to Section 570 and Section 573 of the Companies Act 2006 (the "Act") to allot equity securities (as defined in Section 560(1) of the Act) wholly for cash pursuant to the authority given by that resolution or where the allotment constitutes an allotment of equity securities by virtue of Section 560(3) of the Act, as if Section 561(1) and sub-sections (1) to (6) of Section 562 of the Act did not apply to such allotment, in each case:

  • (A) in connection with a pre-emptive offer; and
  • (B) otherwise than in connection with a pre-emptive offer, up to an aggregate nominal amount of US\$18,422,339;

such authority to expire at the end of the next annual general meeting of the Company or, if earlier, at 6.00 pm on 17 August 2023 but, in each case, prior to its expiry the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the authority given by this Resolution has expired and the Board may allot equity securities (and sell treasury shares) under any such offer or agreement as if the authority had not expired.

For the purposes of this Resolution:

i. " "pre-emptive offer" means an offer of equity securities open for acceptance for a period fixed by the Directors to (a) holders (other than the Company) on the register on a record date fixed by the Directors of Ordinary Shares in proportion (as nearly as may be practicable) to their respective holdings and (b) other persons so entitled by virtue of the rights attaching to any other equity securities held by them. but subject in both cases to such exclusions or other arrangements as the Directors may deem necessary or expedient in relation to treasury shares, fractional entitlements, record dates or legal, regulatory or practical problems in, or under the laws of, any territory;

ii. references to an allotment of equity securities shall include a sale of treasury shares; and

the nominal amount of any securities shall be taken to be, in the case of rights to subscribe for or convert any securities into shares of the Company, the nominal amount of such shares which may be allotted pursuant to such rights.

As a Special Resolution:

Resolution 21: Disapplication of pre-emption rights in comnection with an acquisition or other capital investment

THAT, subject to the passing of Resolution 19 above, the Board be authorised pursuant to Section 570 and Section 573 of the Companies Act 2006 (the "Act") in addition to any authority granted under Resolution 20, to allot equity securities (as defined in Section 560(1) of the Companies Act 2006) wholly for cash pursuant to the authority given by Resolution 19 or where the allotment constitutes an allotment of equity securities by virtue of Section 560(3) of the Companies Act 2006 as if Section 561(1) and subsections (1) to (6) of Section 562 of the Act did not apply to any such allotment, such authority to be:

  • (A) limited to the allotment of equity securities or sale of treasury shares up to an aggregate nominal amount of US\$18,422,339; and
  • (B) used only for the purposes of financing (or refinancing, if the authority is to be used within six months after the original transaction) a transaction which the Board determines to be an acquisition or other capital investment of a kind contemplated by the Statement of Principles on Disapplying Pre-Emption Rights published by the Pre-Emption Group in March 2015,

such authority to expire at the end of the next AGM of the Company (or, if earlier, at 6.00 pm on 17 August 2023) but, in each case, prior to its expiry the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the authority given by this resolution has expired and the Board may allot equity securities (and sell treasury shares) under any such offer or agreement as if the authority had not expired.

As a Special Resolution:

Resolution 22: Authority to purchase own shares

THAT, the Company be and is hereby generally and unconditionally authorised for the purpose of section 701 of the Companies Act 2006 (the "Act") to make market purchases (as defined in section 693 of the Act) of Ordinary Shares in the capital of the Company, provided that:

  • (a) the maximum number of Ordinary Shares that may be purchased is 73,689,358;
  • (b) value of such share;
  • (c) to 5% above the average of the middle market quotation for the Company's Ordinary Shares as derived from the London Stock Exchange's Daily Official List for the five business days' prior to the day on which such share is contracted to be purchased and (ii) the higher of the price of the last independent trade and the highest current bid for an Ordinary Share as derived from the London Stock Exchange Trading System;
  • (d) this authority shall expire at the conclusion of the next annual general meeting of the Company or, if earlier at 6.00 pm on 17 August 2023, unless such authority is previously renewed, varied or revoked by the Company in a general meeting; and
  • (e) the Company may enter into a contract to purchase its Ordinary Shares under this authority prior to its expiry, which will or may be executed wholly or partly after such expiry, and the Company may purchase its Ordinary Shares in pursuance of any such contract.

As a Special Resolution:

Resolution 23: Notice Period of general meetings

THAT a general meeting, other than an annual general meeting, may be called on not less than 14 clear days' notice, provided that facilities are available to shareholders to vote by electronic means for meetings called at such notice.

As a Special Resolution:

Resolution 24: Ratification of distributions

THAT in relation to the dividends paid by the Company on 30 December 2011, 11 September 2012, 10 September 2013, 11 November 2013, 7 September 2018, 24 May 2019 and 6 September 2019 (capitalised terms used in Resolution 24 and not otherwise defined shall have the same meanings as those attributed in the Notice of Annual General Meeting issued by the Company dated 13 April 2022):

the Company hereby ratifies and confirms:

the payment of 41.85 US cents per Ordinary Share by way of interim dividend paid on 30 December 2011 and the appropriation, for the purposes of the Company's audited financial statements for the financial year ended 31 December 2011, of the distributable profits of the Company to the payment of such interim dividend and the resulting entry for the distributable profits of the Company in such financial statements;

the payment of 15,5 US cents per Ordinary Share by way of interim dividend paid on 11 September 2012 and the appropriation, for the purposes of the preparation of the Company's audited financial statements for the financial year ended 31 December 2012, of the distributable profits of the Company to the payment of such interim dividend and the resulting entry for the distributable profits of the Company in such financial statements;

the payment of 4,9 US cents per Ordinary Share by way of interim dividend paid on 10 September 2013 and the appropriation, for the purposes of the preparation of the Company's audited financial statements for the financial year ended 31 December 2013, of the distributable profits of the Company to the payment of such interim dividend and the resulting entry for the distributable profits of the Company in such financial statements;

the payment of 22.39 US cents per Ordinary Share by way of extraordinary dividend paid on 11 November 2013 and the appropriation, for the purposes of the preparation of the Company's audited financial statements for the financial year ended 31 December 2013, of the distributable profits of the Company to the payment of such interim dividend and the resulting entry for the distributable profits of the Company in such financial statements;

the payment of 10.7 US cents per Ordinary Share by way of interim dividend paid on 7 September 2018 and the appropriation, for the purposes of the preparation of the Company's audited financial statements for the financial year ended 31 December 2018, of the distributable profits of the Company to the payment of such interim dividend and the resulting entry for the distributable profits of the Company in such financial statements;

the payment of 16.7 US cents per Ordinary Share by way of final dividend paid on 24 May 2019 and the appropriation. for the purposes of the preparation of the Company's audited financial statements for the financial year ended 31 December 2019, of the distributable profits of the Company to the payment of such interim dividend and the resulting entry for the distributable profits of the Company in such financial statements; and

the payment of 2.6 US cents per Ordinary Share by way of interim dividend paid on 6 September 2019 and the appropriation, for the purposes of the preparation of the Company's audited financial statements for the financial year ended 31 December 2019, of the distributable profits of the Company to the payment of such interim dividend and the resulting entry for the distributable profits of the Company in such financial statements;

any and all claims which the Company has or may have arising out of or in connection with the payment of the Relevant Distributions against its shareholders who appeared on the register of shareholders on the relevant record date for each Relevant Distribution (or the personal representatives and their successors in title (as appropriate) of a shareholder's estate if he or she is deceased) be waived and released pursuant to a deed of release in favour of such shareholders (or the personal representatives and their successors in title (as appropriate) of a shareholder's estate if he or she is deceased), to be entered into by the Company in the form produced to the Annual General Meeting and any two Directors be authorised to execute the same as a deed poll for and on behalf of the Company; and

any and all claims which the Company has or may have against each Relevant Director or the personal representatives and their successors in title (as appropriate) of their estate if such Relevant Director is deceased, arising out of or in connection with the approval, declaration or payment of the Relevant Distributions be waived and released pursuant to a deed of release in favour of each of such Relevant Director (or the personal representatives and their successors in title (as appropriate) of their estate if such Relevant Director is deceased), to be entered into by the Company in the form produced to the Annual General Meeting and any two Directors be authorised to execute the same as a deed poll for and on behalf of the Company.

Gerardo Carreto Company Secretary 17 May 2022